![[logo] US EPA](http://www.epa.gov/epafiles/images/logo_epaseal.gif){kind=logo}
Index of Cleared Science Reviews
Index for Cyproconazole (Pc Code 128993)
December 5, 1988. DER. 13 Page(s).
H. Nelson. Environmental Fate & Groundwater Branch.
Study 5; Field Dissipation - Terrestrial (164-1)
MRID 00406077.
December 5, 1988. DER. 7 Page(s).
H. Nelson. Environmental Fate & Groundwater Branch.
Study 6; Field Dissipation - Terrestrial (164-1)
MRID 40624301.
January 16, 1989. Memorandum. 248 Page(s).
K. Clark Swentzel. Toxicology Branch 2.
Cyproconazole Technical and Cyproconazole 40 WG: Evaluation
of Toxicity Data Submitted to Support Registration for Non-
Food Uses. MRID 406069-05 thru 09, 406077-14 thru 17,
406077-20, 23 thru 29, 406243-04 thru 07.
Tox review 007003.
Attachment(s) following:
January 16, 1989. Memorandum. Page(s).
K. Clark Swentzel. Toxicology Branch 2.
(continued)
Pages 12-19 removed, draft label.
Pages 30-32, 36-37, 42-46, 64, 75, 90, 100-102, 112-131,
141-156, 158-164, 187, 193-194, 207-208, 212-214, 218-219,
223-227, 231-232, 238-248 removed, registrant data.
January 17, 1989. Memorandum. 19 Page(s).
K. Clark Swentzel. Toxicology Branch 2.
Cyproconazole Technical and Cyproconazole 40 WG: Evaluation
of Toxicity Data Submitted to Support Registration for Non-
food Uses.
55947-RGG, 55947-RGE
Pages 12-19 removed-draft label.
June 29, 1989. Memorandum. 2 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole: Response to the Evaluation of an In Vivo
Mouse Micronucleus Assay (Accession no. 406077-28;
Laboratory Project ID 249.215.005)
Tox review 007283.
June 29, 1989. Memorandum. 2 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole (SAN 619F) WG 40: Requested Waiver for the
Requirement of a 21-Day Dermal Toxicity Study
55947-RGE
Tox review 007282.
July 11, 1989. Memorandum. 7 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole Technical: Second Primary Eye Irritation Study
55947-RGG
Tox review 007325
Pages 4-6 removed-registrant data.
December 1, 1989. Memorandum. 20 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole - In Vitro Chromosome Assay with Chinese
Hamster Ovary (CHO) Cells
Pages 12-13, 15-16, 18-20 removed, registrant data.
55947-RGG. MRID 411587-01.
Tox review 007632.
February 5, 1990. Memorandum. 3 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole-Supplemental Data for a Developmental Toxicity
Study in Rats
55947-RGG
Tox review 007730.
February 26, 1990. Memorandum. 2 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole 40 WG. Waiver request for an acute inhalation
study.
55947-RGE.
February 28, 1990. Memorandum. 6 Page(s).
Linda Taylor. Toxicology Branch II.
Cyproconazole - Draft Protocol for a
Dermal Penetration Study
55947-RGG.
April 10, 1990. Data Eval. Rec. 24 Page(s).
Robert Weir. Dynamac Corporation.
Chronic Toxicity/Oncogenicity Feeding Study in Rats
Tox review 007871. MRID 411647-01.
April 23, 1990. Memorandum. 16 Page(s).
Linda Taylor. Toxicology Branch II.
Cyproconazole - Dog Chronic Feeding Study and Rat
Chronic Feeding/Oncogenicity Studies
55947-RGG
Tox review 007871. MRID 412129-01, 411647-01.
Pages 14-16 removed-registrant data.
May 7, 1990. Memorandum. 4 Page(s).
Jess Rowland. Toxicology Branch II.
Cyproconazole (SAN619F): Request by Sandoz Crop
Protection Corporation to Establish a NOEL in a 13-
week Feeding Study in Rats and to Accept the Study
for Regulatory Purposes.
Tox review 007907. MRID 406077-18.
May 7, 1990. Memorandum. 7 Page(s).
Jess Rowland. Toxicology Branch II.
Cyproconazole (SAN 619F): Review of Compound
Stability Data and Sampling Techniques in Response
to EPA Evaluation of a 2-Generation Rat Reproduction
Study with SAN 619 F Technical
Tox review 007908. MRID 412945-00.
May 29, 1990. Memorandum. 9 Page(s).
Bernice Fisher. Science Analysis and Coordination Branch.
Cyproconazole(SAN 619F)- Qualitative Risk Assessment,
Mouse (CD-1) Study
Tox review 008014.
June 7, 1990. Data Eval. Rec. 24 Page(s).
Robert Weir. Dynamac Corporation.
Oncogenicity Feeding Study in Mice (Guideline 83-2)
MRID 411472-01.
June 14, 1990. Memorandum. 172 Page(s).
Esther Rinde. Health Effects Division.
Peer review of Cyproconazole
Pages 81-82, 84-85, 87-89, 101-103, 165-167 removed,
registrant data.
June 20, 1990. Memorandum. 2 Page(s).
Kerry Dearfield. Science Analysis & Coordination Branch.
Additional Mutagenicity Study for Cyproconazole.
June 27, 1990. Memorandum. 2 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole - Mouse Carcinogenicity Study
55947-RGG
MRID 411472-01
Tox review 008009.
September 26, 1990. Memorandum. 15 Page(s).
Patricia McLaughlin. Toxicology Branch II.
Peer Review of Cyproconazole
Tox review 008352.
October 16, 1990. Memorandum. 5 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole 40 WG. Waiver request for an acute inhalation
study
55947-RGE
Pages 3-5 removed-registrant data.
October 17, 1990. Memorandum. 14 Page(s).
Linda Taylor. Toxicology Branch II.
Cyproconazole - Rat Metabolism Study In
Support of Coffee Import Tolerance Petition
MRID 415349-01. PP# 0E3875.
Tox review 008129.
Pages 8-13 removed-registrant data.
December 3, 1990. Memorandum. 2 Page(s).
Karen Whitby. Toxicology Branch II.
Cyproconazole - Supplemental Data for a Developmental
Toxicity Study in Rats
MRID No. 416526-00.
June 27, 1991. Memorandum. 27 Page(s).
Akiva Abramovitch. Environmental Fate & Ground Water Branch.
Review aerobic soil metabolism study and company's response
to adsorption/desorption review. MRID Nos. 41441301, and
41474401.
Pages 8-21 deleted - registration data.
August 21, 1991. Memorandum. 37 Page(s).
Esther Rinde. Health Effects Division.
Second Carcinogenicity Peer Review Meeting on
Cyproconazole.
August 29, 1991. Memorandum. 57 Page(s).
Akiva Abramovitch. Environmental Fate & Ground Water Branch.
Review Terrestrial Field Dissipation Studies for support of
turf use. MRID Nos. 41384101, 41384102, 41461501, 41800701,
41800702, and 41384105.
Pages 10-11, 15-22, 25-31, 34-40, 43-50, and 53-57 deleted -
registration data.
April 29, 1992. Memorandum. 12 Page(s).
Linda Taylor. Toxicology Branch II.
Second Carcinogenicity Peer Review of Cyproconazole.
May 14, 1992. Memorandum. 2 Page(s).
Bernice Fisher. Science Analysis & Coordination Branch.
Cyproconazole, Quantitative Risk Assessment,
CD-1 Mouse Dietary Study.
June 18, 1992. Memorandum. 2 Page(s).
Bernice Fisher. Science Analysis & Coordination Branch.
Cyproconazole, Revised Quantitative Risk Assessment,
CD-1 Mouse Dietary Study.
September 21, 1992. Memorandum. 3 Page(s).
Reto Engler. Health Effects Division.
Cyproconazole: Is a Repeat Rat Study Needed for a
Carcinogenicity Risk Assessment?.
December 4, 1992. Memorandum. 5 Page(s).
Linda Taylor. Toxicology Branch II.
Cyproconazole (Third Meeting): Reclassification
from a Group C with Quantitation to a Group B2
Carcinogen.
March 1, 1993. Memorandum. 42 Page(s).
Akiva Abramovitch. Environmental Fate & Ground Water Branch.
Review bareground terrestrial field dissipation studies for
new chemical registration. MRID Nos. 42430701 & 42489702.
Guideline 164-1.
Pages 10-23 and 27-36 deleted - registration data.
June 11, 1993. Memorandum. 27 Page(s).
Akiva Abramovitch. Environmental Fate & Groundwater Branch.
Purpose: To review ancillary aerobic soil metabolism data.
MRID 42534801 S. Guideline 162-1.
Pages 8-27 removed-registrant data.
July 9, 1993. MEMORANDUM. 2 Page(s).
Linda Taylor. Toxicology Branch.
Cyproconazole: Pathology Report Summary of 13-Week Feeding
Study in Rats - Marked 6(a)(2).
MRID 427449-00 & 01.
August 17, 1993. Memorandum. 7 Page(s).
George Ghali. Health Effects Division.
RfD/ Peer Review Report of Cyproconazole.
March 30, 1994. Memorandum. 20 Page(s).
Linda Taylor. Toxicology Branch.
Cyproconazole: 13-Week Feeding Study in Rats Marked 6(a)(2).
MRID 430786-01
Tox Review #010879.
April 12, 1995. Memorandum. 4 Page(s).
Linda Taylor. Toxicology Branch.
Cyproconazole: 13-Week Feeding Study in Rats Registrant's
Response to TB II Review
End of February 1999.